News
- Advanced hepatocarcinoma: positive results from the Cabozantinib study, in which Humanitas also took part
- Ulcerative colitis: positive opinion for tofacitinib, also thanks to the studies of Prof. Danese
- “Protect your brain from alcohol and drugs”: a meeting in ‘Crema’ with Prof. Giulio Maira
- Seminal fluid biopsy for prostate cancer diagnosis: promising first results from a Humanitas study
- Testicular cancer: What are the possible symptoms?
- Disc protrusion and herniated disc: what are they and how do you intervene?
- Systemic lupus erythematosus: signs that should not be underestimated
- Sepsis: A protein predicts the prognosis and risk of mortality. The results of a study in which Humanitas also took part
- Lumbar back pain: Dr. Fornari on Buongiorno benessere on Rai1
- From diverticulosis to diverticulitis: Prof. Danese on TV2000
- Managing and relieving pain: the role of analgesic therapy
- Physical activity: Professor Lucini dispels false myths on Radio24
- Towards an Individualized Cure: Advances in the Treatment of Breast Tumors
- Dermatitis and stress: what is the link?
- Advice on bowel health, Dr. Salvioli live on Facebook on Radio24
- Asthma: from symptoms to personalized therapy; Prof. Canonica on ‘Tutta Salute’ on Rai3
- ALEX, the new test for molecular allergological diagnosis: a published study by Humanitas specialists
- Advances in Research in Oncology and Hematology: live Facebook stream with Prof. Santoro, Prof. Simonelli and Dr. Rossi
- Colorectal cancer: two markers to understand the immune response after surgery; Humanitas on The Lancet
- EASL 2018: medicines for liver cirrhosis and risk of liver cancer, the encouraging results of an Italian study coordinated by Humanitas
- Value based healthcare prize 2018: Humanitas wins an important international award